BRISTOL-MYERS SQUIBB COMPANY
Federal contract awards won by BRISTOL-MYERS SQUIBB COMPANY (UEI UFGKB2B71N12), 2022–2026 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
63
awards
$15,241,100,345
total value
1
agency
Agencies buying from BRISTOL-MYERS SQUIBB COMPANY
What BRISTOL-MYERS SQUIBB COMPANY sells
Awards
CAMZYOS AND POMALYST
Department of Veterans Affairs · $1,049,820 · Oct 1, 2026
BREYANZI INJECTION
Department of Veterans Affairs · $364,139 · Sep 11, 2026
ABECMA INJECTION
Department of Veterans Affairs · $378,650 · Aug 10, 2026
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)
Department of Veterans Affairs · $300,000 · Aug 2, 2026
EMERGENCY BREYANZI
Department of Veterans Affairs · $364,139 · Jun 30, 2026
BREYANZI CAR-T TRANSPLANT.
Department of Veterans Affairs · $364,139 · Jun 26, 2026
BREYANZI CAR-T
Department of Veterans Affairs · $364,139 · Jun 22, 2026
BREYANZI CAR T
Department of Veterans Affairs · $364,139 · Jun 18, 2026
BREYANZI CAR T - TRANSPLANT
Department of Veterans Affairs · $364,139 · Jun 18, 2026
BREYANZI CAR T - TRANSPLANT
Department of Veterans Affairs · $364,139 · Jun 18, 2026
BREYANZI CAT-T TRANSPLANT
Department of Veterans Affairs · $364,139 · Jun 11, 2026
BREAYNAZI FOR CAR-T TRANSPLANT MEDICATION
Department of Veterans Affairs · $364,139 · Jun 2, 2026
BREYANZI CAR T-TRANSPLANT
Department of Veterans Affairs · $364,139 · May 29, 2026
BREYANZI
Department of Veterans Affairs · $335,043 · Mar 16, 2026
ABECMA FOR CAR-T
Department of Veterans Affairs · $378,650 · Mar 13, 2026
REVLIMID
Department of Veterans Affairs · $87,598,508 · Feb 5, 2026
MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)
Department of Veterans Affairs · $365,117 · Jan 29, 2026
BREYANZI CAR T CELL THERAPY
Department of Veterans Affairs · $335,043 · Jan 21, 2026
BPA FOR CAMZYOS, POMALYST, AND THALOMID
Department of Veterans Affairs · $2,853,029,285 · Jan 16, 2026
MAVACAMTEN IS AN OUTPATIENT DRUG USED IN THE TREATMENT OF SPECIFIC TYPES OF CARDIOMYOPATHIES.
Department of Veterans Affairs · $327,534 · Jan 15, 2026
REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS
Department of Veterans Affairs · $848,445 · Dec 31, 2025
BREYANZI FOR CAR T
Department of Veterans Affairs · $335,043 · Dec 15, 2025
ABECMA TRANSPLANT DRUG
Department of Veterans Affairs · $338,933 · Dec 5, 2025
BREYANZI CAR T THERAPY FOR TVHS TRANSPLANT CENTER
Department of Veterans Affairs · $335,043 · Oct 27, 2025
ABECMA FOR CAR-T
Department of Veterans Affairs · $338,933 · Oct 9, 2025
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids